This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1998 May;28(5):910-1.

doi: 10.1016/s0168-8278(98)80244-4.

A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus

K Ikeda, H Kumada, S Saitoh, Y Suzuki, M Kobayashi, A Tsubota, I Koida, M Fukuda, Y Arase, K Chayama, N Murashima, T Tango

PMID: 9625329
DOI: 10.1016/s0168-8278(98)80244-4

Clinical Trial

A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus

K Ikeda et al. J Hepatol. 1998 May.

. 1998 May;28(5):910-1.

doi: 10.1016/s0168-8278(98)80244-4.

Authors

K Ikeda, H Kumada, S Saitoh, Y Suzuki, M Kobayashi, A Tsubota, I Koida, M Fukuda, Y Arase, K Chayama, N Murashima, T Tango

PMID: 9625329
DOI: 10.1016/s0168-8278(98)80244-4

No abstract available

PubMed Disclaimer

Similar articles

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M. Wright TL, et al. Hepatology. 1994 Oct;20(4 Pt 1):773-9. doi: 10.1002/hep.1840200402. Hepatology. 1994. PMID: 7927216 Clinical Trial.
Clinical decisions. Management of incidental hepatitis C virus infection.
Afdhal NH, Lok AS, Di Bisceglie AM. Afdhal NH, et al. N Engl J Med. 2009 Apr 30;360(18):1902-6. doi: 10.1056/NEJMclde0900131. N Engl J Med. 2009. PMID: 19403909 No abstract available.
SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders.
Sarrazin C, Rouzier R, Wagner F, Forestier N, Larrey D, Gupta SK, Hussain M, Shah A, Cutler D, Zhang J, Zeuzem S. Sarrazin C, et al. Gastroenterology. 2007 Apr;132(4):1270-8. doi: 10.1053/j.gastro.2007.01.041. Epub 2007 Jan 25. Gastroenterology. 2007. PMID: 17408662 Clinical Trial.
Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Douglas DD, Rakela J, Lin HJ, Hollinger FB, Taswell HF, Czaja AJ, Gross JB, Anderson ML, Parent K, Fleming CR, et al. Douglas DD, et al. Dig Dis Sci. 1993 Apr;38(4):601-7. doi: 10.1007/BF01316787. Dig Dis Sci. 1993. PMID: 8384978 Clinical Trial.
Hepatitis C: clinical aspects.
Main J. Main J. J Infect. 1995 Mar;30(2):103-6. doi: 10.1016/s0163-4453(95)80003-4. J Infect. 1995. PMID: 7636275 Review. No abstract available.

See all similar articles

Cited by

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Koretz RL, Pleguezuelo M, Arvaniti V, Barrera Baena P, Ciria R, Gurusamy KS, Davidson BR, Burroughs AK. Koretz RL, et al. Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD003617. doi: 10.1002/14651858.CD003617.pub2. Cochrane Database Syst Rev. 2013. PMID: 23440791 Free PMC article.
Interferon for interferon naive patients with chronic hepatitis C.
Myers RP, Regimbeau C, Thevenot T, Leroy V, Mathurin P, Opolon P, Zarski JP, Poynard T. Myers RP, et al. Cochrane Database Syst Rev. 2002;2002(2):CD000370. doi: 10.1002/14651858.CD000370. Cochrane Database Syst Rev. 2002. PMID: 12076394 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information